Adriamycin Cardiotoxicity: possible pathogenic mechanisms.
D000200:Action Potentials / Q000187:drug effects; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002642:Chick Embryo; D002645:Chickens; D000242:Cyclic AMP / Q000378:metabolism; D004317:Doxorubicin / Q000494:pharmacology*; D004553:Electric Conductivity; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D008929:Mitochondria, Heart / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism*; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D013779:Tetrodotoxin / Q000494:pharmacology
D013779:Tetrodotoxin; D004317:Doxorubicin; D000255:Adenosine Triphosphate; D000242:Cyclic AMP